Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Mallinckrodt boosts buyback plan amid news of a 2,000% price hike on infant drug
Mallinckrodt boosts buyback plan amid news of a 2,000% price hike on infant drug
Mallinckrodt boosts buyback plan amid news of a 2,000% price hike on infant drug
Submitted by
admin
on November 19, 2015 - 4:47pm
Source:
Fierce Pharma
News Tags:
Mallinckrodt
share repurchase
Synacthen Depot
Headline:
Mallinckrodt boosts buyback plan amid news of a 2,000% price hike on infant drug
Do Not Allow Advertisers to Use My Personal information
